[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EG13869A - Process for preparing of penicillanic acid derivates as antibacterials agent and enhacing the effectiveness of b-lactamase - Google Patents

Process for preparing of penicillanic acid derivates as antibacterials agent and enhacing the effectiveness of b-lactamase

Info

Publication number
EG13869A
EG13869A EG322/78A EG32278A EG13869A EG 13869 A EG13869 A EG 13869A EG 322/78 A EG322/78 A EG 322/78A EG 32278 A EG32278 A EG 32278A EG 13869 A EG13869 A EG 13869A
Authority
EG
Egypt
Prior art keywords
enhacing
lactamase
effectiveness
preparing
penicillanic acid
Prior art date
Application number
EG322/78A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG13869(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG13869A publication Critical patent/EG13869A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EG322/78A 1977-06-07 1978-05-20 Process for preparing of penicillanic acid derivates as antibacterials agent and enhacing the effectiveness of b-lactamase EG13869A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US87938178A 1978-02-21 1978-02-21

Publications (1)

Publication Number Publication Date
EG13869A true EG13869A (en) 1983-03-31

Family

ID=27122691

Family Applications (1)

Application Number Title Priority Date Filing Date
EG322/78A EG13869A (en) 1977-06-07 1978-05-20 Process for preparing of penicillanic acid derivates as antibacterials agent and enhacing the effectiveness of b-lactamase

Country Status (35)

Country Link
AR (1) AR224111A1 (es)
AT (2) AT360649B (es)
AU (1) AU513636B2 (es)
BE (1) BE867859A (es)
BG (2) BG34615A3 (es)
CH (1) CH634073A5 (es)
CS (1) CS208472B2 (es)
DD (2) DD140888A5 (es)
DE (2) DE2857263C3 (es)
DK (1) DK155740C (es)
EG (1) EG13869A (es)
FI (1) FI66003C (es)
FR (2) FR2393804A1 (es)
GB (1) GB2000138B (es)
GR (1) GR72255B (es)
HK (1) HK13184A (es)
HU (1) HU180042B (es)
IE (1) IE47079B1 (es)
IL (2) IL54867A (es)
IN (1) IN149747B (es)
IT (1) IT1096381B (es)
KE (1) KE3355A (es)
LU (1) LU79774A1 (es)
MY (1) MY8500092A (es)
NL (2) NL180009C (es)
NO (2) NO151746C (es)
NZ (1) NZ187476A (es)
OA (1) OA05964A (es)
PH (3) PH26810A (es)
PL (1) PL114501B1 (es)
PT (1) PT68146A (es)
SE (2) SE436206B (es)
SG (1) SG65383G (es)
SU (1) SU860706A1 (es)
YU (1) YU41829B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (es) * 1977-05-09 1979-01-18
DE2912511C2 (de) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmazeutische Zusammensetzung, enthaltend Penicillansäure
DK155942C (da) * 1977-12-23 1989-10-23 Pfizer Analogifremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid og fysiologisk acceptable syreadditions- og basesalte deraf.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
SE449103B (sv) * 1979-03-05 1987-04-06 Pfizer Sett att framstella penicillansyra-1,1-dioxid samt estrar derav
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4309347A (en) * 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
IL59948A0 (en) * 1979-05-21 1980-06-30 Rech Applications Therap Penicillanic acid derivatives,their production and pharmaceutical compositions containing them
DE3051044C2 (es) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
DE3261759D1 (en) * 1981-07-15 1985-02-14 Kanebo Ltd Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76527B (en) * 1982-04-19 1985-12-09 Gist Brocades Nv A process for the preparation of penicillanic acid 1,1-dioxide and derivatives thereof
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
WO1987006230A1 (en) * 1986-04-10 1987-10-22 Leo Pharmaceutical Products Ltd. A/S Method for preparing penicillanic acid derivatives
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (zh) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 一种舒巴坦匹酯制备及结晶方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (es) * 1977-05-09 1979-01-18
AU3796278A (en) * 1977-07-13 1980-01-17 Glaxo Group Ltd Penams and azetidinones

Also Published As

Publication number Publication date
NO151746B (no) 1985-02-18
IT7824270A0 (it) 1978-06-06
NZ187476A (en) 1982-08-17
DE2857263B2 (de) 1981-04-23
DD140888A5 (de) 1980-04-02
DK155740C (da) 1989-10-23
SU860706A1 (ru) 1981-08-30
CH634073A5 (en) 1983-01-14
NL7806126A (nl) 1978-12-11
MY8500092A (en) 1985-12-31
DE2857263C3 (de) 1981-12-17
GB2000138A (en) 1979-01-04
PH21116A (en) 1987-07-16
YU41829B (en) 1988-02-29
DE2824535A1 (de) 1978-12-14
NO781970L (no) 1978-12-08
IT1096381B (it) 1985-08-26
AT360649B (de) 1981-01-26
SE8305916L (sv) 1983-10-27
ATA411278A (de) 1980-06-15
FI66003C (fi) 1984-08-10
YU117078A (en) 1983-01-21
NL930064I1 (nl) 1993-09-01
IE781140L (en) 1978-12-07
FI66003B (fi) 1984-04-30
NL180009C (nl) 1986-12-16
FR2393805B1 (es) 1984-02-24
BG34615A3 (en) 1983-10-15
FR2393804B1 (es) 1980-11-07
BE867859A (fr) 1978-12-06
FR2393804A1 (fr) 1979-01-05
PH26810A (en) 1992-11-05
HK13184A (en) 1984-02-24
IN149747B (es) 1982-04-03
DK251478A (da) 1978-12-08
FR2393805A1 (fr) 1979-01-05
SE7806628L (sv) 1978-12-08
IL62168A0 (en) 1981-03-31
HU180042B (en) 1983-01-28
NO152448B (no) 1985-06-24
PL114501B1 (en) 1981-02-28
AT364084B (de) 1981-09-25
GR72255B (es) 1983-10-06
NL930064I2 (nl) 1994-04-18
CS208472B2 (en) 1981-09-15
AR224111A1 (es) 1981-10-30
AU3683878A (en) 1979-12-06
IL54867A (en) 1981-11-30
KE3355A (en) 1983-12-16
DD148585A5 (de) 1981-06-03
DK155740B (da) 1989-05-08
SE8305916D0 (sv) 1983-10-27
NO823126L (no) 1978-12-08
SE436206B (sv) 1984-11-19
FI781800A (fi) 1978-12-08
OA05964A (fr) 1981-06-30
PH16465A (en) 1983-10-20
DE2824535C3 (de) 1981-01-22
AU513636B2 (en) 1980-12-11
NO152448C (no) 1985-10-02
SE447995B (sv) 1987-01-12
PT68146A (en) 1978-07-01
GB2000138B (en) 1982-03-03
IL54867A0 (en) 1978-08-31
LU79774A1 (fr) 1980-01-22
ATA128580A (de) 1981-02-15
SG65383G (en) 1985-03-29
BG34614A3 (en) 1983-10-15
PL207396A1 (pl) 1979-06-04
NO151746C (no) 1985-06-05
DE2824535B2 (de) 1980-05-14
IE47079B1 (en) 1983-12-14

Similar Documents

Publication Publication Date Title
EG13869A (en) Process for preparing of penicillanic acid derivates as antibacterials agent and enhacing the effectiveness of b-lactamase
RO75478B (ro) Procedeu pentru prepararea unor derivati ai acidului alfa-fenoxipropionic
GR65303B (en) Process for preparation of phthalazin-4-ylacetic acid derivatives
DE2861547D1 (en) Process for the preparation of 6- d-alpha-amino-(p-hydroxyphenyl)-acetamido penicillanic acid
JPS54160317A (en) Manufacture of dimethylaminomethylene bisphosphoric acid
YU40004B (en) Praocess for preparing n-substituted esters of 9,10-dihydrlysergic acid
YU210977A (en) Process for obtaining unsaturated derivatives of 7-acylamido-3-cephem-4-carboxylic acid
JPS5419913A (en) Alphaahalomethyl derivative of alphaaamino acid
GR63768B (en) Process for preparation of esters oxalic acid
EG12936A (en) Process for preparing of thiazolylcinnamic acid nitrilles and their use as pesticides
GB2001637B (en) Process for the preparation of tobias acid
GB2001640B (en) Process for the preparation of tobias acid
AU3728478A (en) Derivatives of amidinopenicillanic acid
JPS5479226A (en) Method of obtaining asparagic acid salt
YU204778A (en) Process for preparing n-substituted derivatives of 2-hydrazonopropionic acid
CS194835B2 (en) Process for preparing active component of antinefrolithiatic agent
GB2002750B (en) Process for the production of n-substituted alpha-ketocarboxylic acid amides
IL55956A (en) Process for the preparation of phosphoric acid
JPS5498764A (en) Manufacture of piperonilidine crotonic acid amides
GB2001644B (en) Process for the preparation of tobias acid
YU39848B (en) Process for the granulation of sodium metasilicate
IL54206A0 (en) Process for the preparation of , -dialkoxycarboxylic acid derivatives
YU135378A (en) Process for the manufacture of new piperazine-dithiocarboxylic acid derivatives
DE2862273D1 (en) Process for the synthesis of esters of parachlorobenzoyl-phenoxy-isobutyric acid
GB2012269B (en) Process for the production of the magnesium salt of nitro armstong's acid